生物反馈治疗仪治疗慢性精神分裂症焦虑情绪与苯二氮卓药物疗效对比研究

A Comparative Study on the Therapeutic Effect of Biofeedback Therapeutic Apparatus on Chronic Schizophrenia Anxiety and Benzodiazepine

目的:探讨生物反馈治疗仪治疗慢性精神分裂症焦虑情绪与苯二氮卓药物疗效。方法:选取本院2018年1月~2019年3月接收的40例慢性精神分裂症患者为研究对象,基于不同的治疗方式将其分为两组。对照组患者(n=20)采用苯二氮卓药物进行治疗,试验组患者(n=20)采用生物反馈治疗仪进行治疗,观察两组患者治疗前后的SAS评分、SANS评分以及SAPS评分。结果:治疗前两组患者的SAS评分、SANS评分以及SAPS评分差异均无统计学意义(P>0.05),治疗后试验组患者的SAS评分和SANS评分分别为(44.32±5.47)分和(45.10±5.36)分,均优于对照组患者(50.37±5.28)分和(51.69±5.41)分,差异有统计学意义(P<0.05),但是两者的SAPS评分差异无统计学意义(P>0.05)。结论:对慢性精神分裂症患者采用生物反馈治疗仪进行治疗,可以更好改善患者的焦虑情绪以及阴性症状。

Objective:To explore the anxiety of chronic schizophrenia and the curative effect of benzodiazepine on the biofeedback therapeutic apparatus.Methods:Forty patients with chronic schizophrenia received in our hospital from January 2018 to March 2019 were selected as the research object,and they were divided into two groups based on different treatment methods.The patients in the control group(n=20)were treated with benzodiazepine drugs,and the patients in the experimental group(n=20)were treated with biofeedback therapy equipment.The SAS score,SANS score and SAPS score of the two groups of patients before and after treatment were observed.Results:There was no significant difference in SAS score,SANS score and SAPS score between the two groups before treatment(P>0.05).After treatment,the SAS score and SANS score of the patients in the experimental group were(44.32±5.47)and(45.10±5.36),which are better than those of the control group(50.37±5.28)and(51.69±5.41),the difference is statistically significant(P<0.05),but the difference between the two SAPS scores is not statistically significant(P>0.05).Conclusion:Treating patients with chronic schizophrenia with biofeedback therapy equipment can better improve patients’anxiety and negative symptoms.